DE MARTIN, SARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.643
EU - Europa 891
AS - Asia 472
SA - Sud America 7
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 2
Totale 6.023
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.639
IT - Italia 473
CN - Cina 319
FI - Finlandia 96
GB - Regno Unito 77
DE - Germania 76
SE - Svezia 74
PK - Pakistan 69
UA - Ucraina 22
FR - Francia 20
IN - India 18
VN - Vietnam 18
TR - Turchia 16
CH - Svizzera 11
IR - Iran 7
RU - Federazione Russa 7
HK - Hong Kong 6
IE - Irlanda 6
TW - Taiwan 6
ES - Italia 5
AT - Austria 4
BR - Brasile 4
DK - Danimarca 4
JP - Giappone 3
RS - Serbia 3
SG - Singapore 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
BD - Bangladesh 2
BE - Belgio 2
CA - Canada 2
CL - Cile 2
EU - Europa 2
HU - Ungheria 2
KE - Kenya 2
KR - Corea 2
LU - Lussemburgo 2
MX - Messico 2
NO - Norvegia 2
AM - Armenia 1
AU - Australia 1
BG - Bulgaria 1
BO - Bolivia 1
CZ - Repubblica Ceca 1
EG - Egitto 1
GH - Ghana 1
GR - Grecia 1
NL - Olanda 1
NZ - Nuova Zelanda 1
PL - Polonia 1
Totale 6.023
Salva come PNG Salva come JPEG
Città #
Fairfield 859
Woodbridge 519
Chandler 438
Ashburn 363
Houston 312
Ann Arbor 311
Cambridge 288
Seattle 273
Wilmington 244
Padova 242
Jacksonville 109
Beijing 101
Princeton 95
San Diego 75
Medford 68
Helsinki 60
Des Moines 52
Roxbury 46
Nanjing 45
Boardman 34
Sahiwal 34
New York 32
Jinan 23
Nanchang 21
Milan 20
Shenyang 19
Dong Ket 17
Venice 16
Lahore 14
London 14
Guangzhou 12
Rome 11
Ankara 10
Hebei 10
Saarbrücken 10
Rawalpindi 9
Redwood City 9
Tianjin 9
Washington 9
Bologna 8
Kilburn 8
Treviso 8
Jiaxing 7
Los Angeles 7
Saint Petersburg 7
Dublin 6
Genova 6
Hounslow 6
Kunming 6
Shanghai 6
Taipei 6
Toba Tek Singh 6
Zhengzhou 6
Hefei 5
Hong Kong 5
Lugano 5
Ogden 5
Binasco 4
Chicago 4
Haikou 4
Ningbo 4
Norwalk 4
Aix-en-Provence 3
Aprilia 3
Cagliari 3
Camparada 3
Changsha 3
Detroit 3
Faisalabad 3
Gujrat 3
Hangzhou 3
Indiana 3
Kolkata 3
Munich 3
Paris 3
Phoenix 3
Pittsburgh 3
San Michele All'adige 3
Sesto Fiorentino 3
Taizhou 3
Talence 3
Vicenza 3
Zurich 3
Al Ain City 2
Baotou 2
Boydton 2
Brendola 2
Budapest 2
Castel San Pietro Terme 2
Chengdu 2
Chiswick 2
Ergolding 2
Fiesso Umbertiano 2
Frankfurt am Main 2
Gent 2
Goyang-si 2
Istanbul 2
Kharkiv 2
Lonigo 2
Lucknow 2
Totale 5.063
Salva come PNG Salva come JPEG
Nome #
Live applications of norbormide-based fluorescent probes in Drosophila melanogaster 174
Flavonoids Regulate Lipid Droplets Biogenesis in Drosophila melanogaster 173
Dopamine–mediated immunomodulation affects choroid plexus function 141
Extrahepatic autoimmunity in autoimmune liver disease 139
The Phytocomplex from Fucus vesiculosus and Ascophyllum nodosum Controls Postprandial Plasma Glucose Levels: An In Vitro and In Vivo Study in a Mouse Model of NASH 138
In vitro hepatic conversion of the anticancer agent nemorubicin to its active metabolite PNU-159682 in mice, rats and dogs: A comparison with human liver microsomes 135
Severe Liver Cirrhosis Markedly Reduces AhR-Mediated Induction of Cytochrome P450 in Rats by Decreasing the Transcription of Target Genes 131
Western Diet-Induced Metabolic Alterations Affect Circulating Markers of Liver Function before the Development of Steatosis 119
Novel Super Stealth immunoliposomes for cancer targeted delivery of doxorubicin: an innovative strategy to reduce liver toxicity 117
Enzyme inhibition and induction in liver disease. 112
An NBD derivative of the selective rat toxicant norbormide as a new probe for living cell imaging 107
The administration of a high-fat diet alters bile acid composition and hepatic drug metabolism in rats 107
Expression and distribution of the adrenomedullin system in newborn human thymus. 103
Effect of CYP3A4 inhibitor erythromycin on the pharmacokinetics of lignocaine and its pharmacologically active metabolites in subjects with normal and impaired liver function 102
Diagnostic value of plasma cystatin C as a glomerular filtration marker in decompensated liver cirrhosis 97
The effect of liver disease on inhibitory and plasma protein-binding displacement interaction:an update. 94
An intracellular adrenomedullin system reduces IL-6 release via a NF-kB-mediated, cAMP-independent transcriptional mechanism in rat thymic epithelial cells 94
Pharmacokinetic drug interactions in liver disease: An update 94
The activation of NF-kB, Pregnane X Receptor, and Constitutive Androstane Receptor is modulated by the degree of cholestasis 92
Antibiotic-induced dysbiosis of the microbiota impairs gut neuromuscular function in juvenile mice 92
Cytochrome P450 1A2 is a major determinant of lidocaine metabolism in vivo: effects of liver function 92
In vitro and in vivo behavior of liposomes decorated with PEGs with different chemical features 91
Etiopathogenesis of autoimmune hepatitis 87
Dexamethasone counteracts hepatic inflammation and oxidative stress in cholestatic rats via CAR activation 86
NAD+-dependent SIRT1 deactivation has a key role on ischemia-reperfusion-induced apoptosis. 85
Pregnane X receptor and constitutive androstane receptor modulate differently CYP3A-mediated metabolism in earlyand late-stage cholestasis 85
Targeting RORs nuclear receptors by novel synthetic steroidal inverse agonists for autoimmune disorders 85
The Cuban Propolis Component Nemorosone Inhibits Proliferation and Metastatic Properties of Human Colorectal Cancer Cells. 85
Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis 81
Super Stealth immunoliposomes as a strategy to overcome liposome-induced liver toxicity 80
The ecto-enzymes CD73 and adenosine deaminase modulate 5′-AMP-derived adenosine in myofibroblasts of the rat small intestine 79
Differential effect of liver cirrhosis on the pregnane X receptor-mediated induction of CYP3A1 and 3A2 in the rat. 78
Co-administration of sirolimus alters tacrolimus pharmacokinetics in a dose-dependent manner in adult renal transplant recipients 78
The brown algae fucus vesiculosus and ascophyllum nodosum reduce metabolic syndrome risk factors: A clinical study 78
Cuban brown propolis interferes in the crosstalk between colorectal cancer cells and m2 macrophages 78
The Extra Virgin Olive Oil Polyphenol Oleocanthal Exerts Antifibrotic Effects in the Liver 78
Irreversible CYP3A Inhibition Accompained by Plasma Protein-Binding Displacement: A Comparative Analysis in Subjects with normal and impaired liver function. 76
Emerging players in liver fibrosis regression in a chronic murine model of hepatic injury 76
Refill liquids for electronic cigarettes display peculiar toxicity on human endothelial cells 76
Fucus vesiculosus and Ascophyllum nodosum Ameliorate Liver Function by Reducing Diet-Induced Steatosis in Rats 74
P383 EFFECT OF PREGNANE X RECEPTOR (PXR) AND CONSTITUTIVE ANDROSTANE RECEPTOR (CAR) ON CYTOCHROME P3A ENZYMES IN AN EXPERIMENTAL MODEL OF CHOLESTASIS 73
Depression and cognitive impairment-Extrahepatic manifestations of NAFLD and NASH 72
Fluvoxamine pharmacokinetics in healthy elderly subjects and elderly patients with chronic heart failure 71
A novel HER2-targeted liposomal formulation for reducing the risk of liposome-induced hepatotoxicity 71
null 69
Liver dysfunction markedly decreases the inhibition of CYP1A2-mediated theophylline metabolism by fluvoxamine 68
Effect of renal flailure on metabolic disposition of lidocaine in patients undergoing and not undergoing hemodialysis 64
How gender influences fibrosis regression in a chronic murine model of hepatic injury 64
Liver dysfunction markedly decreases the inhibition of cytochrome P450IA2-mediated theophylline metabolism by fluvoxamine 63
Expression of adrenomedullin in chronic inflammatory liver diseases 60
Cholangiocyte senescence in primary sclerosing cholangitis is associated with disease severity and prognosis 60
Farmaci citotossici 58
PCSK9 Levels Are Raised in Chronic HCV Patients with Hepatocellular Carcinoma 58
Lomitapide does not alter PCSK9 and Lp(a) levels in homozygous familial hypercholesterolemia patients: analysis on cytokines and lipid profile 56
Nemorosone inhibits the proliferation and migration of hepatocellular carcinoma cells 54
Enzyme induction is independent on liver functional status 53
Impact of bariatric surgery-induced weight loss on circulating PCSK9 levels in obese patients 52
Brown Seaweeds for the Management of Metabolic Syndrome and Associated Diseases 50
Differential inducing effect of benzo[a]pyrene on gene expression and enzyme activity of cytochromes P450 1A1 and 1A2 in Sprague-Dawley and Wistar rats. 49
EXPRESSION OF ADRENOMEDULLIN AND ITS RECEPTOR IN HUMAN THYMUS 47
Glabrescione B delivery by self-assembling micelles efficiently inhibits tumor growth in preclinical models of Hedgehog-dependent medulloblastoma 47
Tyrosine kinase inhibitor prodrug-loaded liposomes for controlled release at tumor microenvironment 47
Fluvoxamine pharmacokinetics in elderly subjects and patients with chronic heart failure 46
Folic acid-targeted paclitaxel-polymer conjugates exert selective cytotoxicity and modulate invasiveness of colon cancer cells 46
In vitro inhibition of cytochrome P450 (CYP) 2C8-mediated drug metabolism by the flavonoid diosmetin 44
Drosophila REEP1 modulates ER morphology and ER stress 44
EFFECT OF PREGNANE X RECEPTOR (PXR) AND CONSTITUTIVE ANDROSTANE RECEPTOR (CAR) ON CYTOCHROME P3A ENZYMES IN AN EXPERIMENTAL MODEL OF CHOLESTASIS 40
The balance between fibrosis and regeneration in chronic liver injury: The role of gender 40
Effect of CYP 3A4 inhibition on lidocaine kinetics and the MEGS liver function test 35
Gut microbial profiling as a therapeutic and diagnostic target for managing primary biliary cholangitis 34
The role of oxidative stress in nafld–nash–hcc transition—focus on nadph oxidases 34
Effect of experimentally induced liver cirrhosis on CYP3A induction in male Wistar rats 32
Primary biliary cholangitis: Perception and expectation of illness in Italian patients 32
Anti-HER2 Super Stealth Immunoliposomes for Targeted-Chemotherapy 31
Ciprofloxacin treatment affects the structure and activity of enteric nervous system in mouse small intestine 31
Differential effect of liver dysfunction on CYP3A1 and CYP3A2 expression in rats with carbon tetrachloride-induced cirrhosis 30
Expression and localization of adrenomedullin and its receptor RAMP2 in human thymus 30
PCSK9 promotes arterial medial calcification 30
REL-1017 (Esmethadone) as Adjunctive Treatment in Patients With Major Depressive Disorder: A Phase 2a Randomized Double-Blind Trial 29
REL-1017 (Esmethadone) Increases Circulating BDNF Levels in Healthy Subjects of a Phase 1 Clinical Study 27
A Nutraceutical Formulation Containing Brown Algae Reduces Hepatic Lipid Accumulation by Modulating Lipid Metabolism and Inflammation in Experimental Models of NAFLD and NASH 25
Principi generali di chemioterapia antineoplastica 24
Improved Trimethylangelicin Analogs for Cystic Fibrosis: Design, Synthesis and Preliminary Screening 19
The nuclear receptor PXR in chronic liver disease 19
Treatment of primary sclerosing cholangitis 18
Self-Emulsifying Formulations to Increase the Oral Bioavailability of 4,6,4′-Trimethylangelicin as a Possible Treatment for Cystic Fibrosis 15
The phenolic compounds tyrosol and hydroxytyrosol counteract liver fibrogenesis via the transcriptional modulation of NADPH oxidases and oxidative stress-related miRNAs 14
The Metabolic Activation of Sofosbuvir Is Impaired in an Experimental Model of NAFLD 13
The Role of Sex in Acute and Chronic Liver Damage 12
Esmethadone-HCl (REL-1017): a promising rapid antidepressant 10
In Vitro and In Vivo Sucrosomial® Berberine Activity on Insulin Resistance 7
Esmethadone (REL-1017) and Other Uncompetitive NMDAR Channel Blockers May Improve Mood Disorders via Modulation of Synaptic Kinase-Mediated Signaling 5
Update on the Pharmacological Treatment of Primary Biliary Cholangitis 5
Toward a New Era in the Management of Hepatocellular Carcinoma: Novel Perspectives on Therapeutic Options and Biomarkers 4
Sex Drives Functional Changes in the Progression and Regression of Liver Fibrosis 3
Drug–Drug Interaction Studies of Esmethadone (REL-1017) Involving CYP3A4- and CYP2D6-Mediated Metabolism 3
COVID-19 and Autoimmune Liver Diseases 3
The novel uncompetitive NMDA receptor antagonist esmethadone (REL-1017) has no meaningful abuse potential in recreational drug users 2
Obeticholic Acid for Primary Biliary Cholangitis 2
REL-1017 (Esmethadone) May Rapidly Reduce Dissociative Symptoms in Adults With Major Depressive Disorder Unresponsive to Standard Antidepressants: A Report of 2 Cases 2
Totale 6.135
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.058
article - articoli 22.568
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 264
Totale 47.890
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019311 0 0 0 0 0 0 0 0 0 66 113 132
2019/20201.351 116 85 81 182 104 79 106 147 179 131 100 41
2020/20211.010 67 61 124 92 39 54 29 87 144 101 130 82
2021/20221.185 62 107 102 62 89 117 53 111 74 79 82 247
2022/20231.038 174 121 26 95 133 123 73 79 100 15 64 35
2023/2024534 29 89 72 57 52 90 55 33 33 24 0 0
Totale 6.139